Acute Myeloid Leukemia (AML): Minimal Residual Disease as a Surrogate Enpoint for Clinical Trials
|
Acute Myeloid Leukemia (AML): Minimal Residual Disease as a Surrogate Enpoint for Clinical Trials
|
T